Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy

被引：0

作者：

Mazeron, MC ^{[1
]}

Fillet, AM

Salmon, D

Boukli, N

Houhou, N

Sénéchal, B

Matheron, S

Gozlan, J

Leport, C

Katlama, C

Scieux, C

Imbert, BM

Deny, P

Bour, JB

Freymuth, F

Chanzy, B

Chaput, S

Costagliola, D

机构：

[1] Hop Lariboisiere, Dept Virol, F-75475 Paris, France

[2] Hop La Pitie Salpetriere, CERVI, Dept Virol, Paris, France

[3] Hop St Antoine, Dept Virol, F-75571 Paris, France

[4] Hop Bichat Claude Bernard, Dept Virol, F-75877 Paris, France

[5] Hop St Louis, Dept Virol, Paris, France

[6] Hop Hotel Dieu, Dept Virol, Nantes, France

[7] Hop Avicenne, Dept Virol, F-93009 Bobigny, France

[8] Hop Boccage, Dept Virol, Dijon, France

[9] Hop G Clemenceau, Dept Virol, Caen, France

[10] Hop Michallon, Dept Virol, Grenoble, France

[11] Hop Cochin, Dept Med, F-75674 Paris, France

[12] Hop Bichat Claude Bernard, Dept Infect Dis, F-75877 Paris, France

[13] Hop La Pitie Salpetriere, Dept Infect Dis, Paris, France

[14] INSERM, EMI 0214, Dept Biostat, Paris, France

来源：

AIDS | 2003年 / 17卷 / 05期

关键词：

D O I：

10.1097/00002030-200303280-00029

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：784 / 786

页数：3

共 50 条

[21] Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy [J].

Miller, TL .

AIDS, 2003, 17 :S130-S140

[22] Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy [J].

Patel, V ;

Hedayati, SS .

NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (02) :109-114

[23] Prevalence of Metabolic Abnormalities in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy and Antiretroviral-Naive Patients [J].

Ramezani, A. ;

Mohraz, M. ;

Jam, S. ;

Banifazl, M. ;

Aghakhani, A. ;

Eslamifar, A. ;

Gachkar, L. ;

Yaghmaie, F. ;

Nemati, K. ;

Velayati, A. A. .

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 :E200-E200

[24] Bacterial disease in HIV-infected patients: The blind spot of highly active antiretroviral therapy? [J].

Noursadeghi, M ;

Ustianowski, A ;

Elgalib, A ;

Miller, R .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (04) :532-535

[25] Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy [J].

Gourlain, K ;

Salmon, D ;

Gault, E ;

Leport, C ;

Katlama, C ;

Matheron, S ;

Costagliola, D ;

Mazeron, MC ;

Fillet, AM .

JOURNAL OF MEDICAL VIROLOGY, 2003, 69 (03) :401-407

[26] Increased access to the emergency department for coronary heart disease of HIV-infected patients receiving highly active antiretroviral therapy [J].

Barbaro, G .

ANNALS OF EMERGENCY MEDICINE, 2002, 40 (05) :530-531

[27] Pruritus in HIV-infected patients in the era of highly active antiretroviral therapy [J].

Blanes, Mar ;

Belinchon, Isabel ;

Betlloch, Isabel ;

Portilla, Joaquin ;

Reus, Sergio .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) :AB119-AB119

[28] Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy [J].

Bernasconi, E ;

Uhr, M ;

Magenta, L ;

Ranno, A ;

Telenti, A .

AIDS, 2001, 15 (08) :1081-1082

[29] Hospitalized HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy [J].

Metsch, Lisa R. ;

Bell, Christine ;

Pereyra, Margaret ;

Cardenas, Gabriel ;

Sullivan, Tanisha ;

Rodriguez, Allan ;

Gooden, Lauren ;

Khoury, Nayla ;

Kuper, Tamy ;

Brewer, Toye ;

del Rio, Carlos .

AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 99 (06) :1045-1049

[30] Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy [J].

Foulon, G ;

Wislez, M ;

Naccache, JM ;

Blanc, FX ;

Rabbat, A ;

Israël-Biet, D ;

Valeyre, D ;

Mayaud, C ;

Cadranel, J .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) :418-425

← 1 2 3 4 5 →